VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!

Dr. Butowski on Real-Time Imaging of Nanoliposomal Irinotecan Injection

Nicholas A. Butowski, MD
Published: Sunday, Nov 22, 2015

Nicholas A. Butowski, MD, director, Translational Research in Neuro-Oncology, University of California, San Francisco, discusses an early-stage study of convection-enhanced delivery of nanoliposomal irinotecan with real-time imaging. These findings were reported on at the 2015 Annual Meeting of the Society for Neuro-Oncology.

Imaging a patient during injection has two benefits: a physician can make sure the target is being hit and can also correct any problems that might arise. Prior studies have used convection-enhanced delivery, Butowski says, but have not paired it with real-time imaging.

In this phase I study, researchers sought out to prove safety of the method.

Butowski hopes to take the strategy to the next level, though, by enhancing the delivery and reducing cost.

<<< View more from the 2015 SNO Meeting

Nicholas A. Butowski, MD, director, Translational Research in Neuro-Oncology, University of California, San Francisco, discusses an early-stage study of convection-enhanced delivery of nanoliposomal irinotecan with real-time imaging. These findings were reported on at the 2015 Annual Meeting of the Society for Neuro-Oncology.

Imaging a patient during injection has two benefits: a physician can make sure the target is being hit and can also correct any problems that might arise. Prior studies have used convection-enhanced delivery, Butowski says, but have not paired it with real-time imaging.

In this phase I study, researchers sought out to prove safety of the method.

Butowski hopes to take the strategy to the next level, though, by enhancing the delivery and reducing cost.

<<< View more from the 2015 SNO Meeting


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
34th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series™May 25, 20182.0
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Publication Bottom Border
Border Publication
x